GBAF Logo
Global Banking & Finance Awards® 2026 Nominations open, free to enter Nominate now →
U

US Stem Cell USRM · USD

Health Care · US listing · 🇺🇸 United States

Compare

0.00

—

Close of 9 Nov 2026, in USD

Search any instrument

Reference data, closing prices and charts across 45,000 companies, plus crypto, commodities and currencies.

Price performance

Chart by TradingView, with its own licensed prices

US Stem Cell — daily USRM Delayed
Market value
$59,156
Last close × shares
Volume
31k
Shares, 9 Nov 2026

About US Stem Cell

Its shares trade under the ticker USRM. It has been listed since 19 February 2008. In the fiscal year to 31 December 2022, it reported revenue of $82,049 and a net loss of $2.9m. At that date it held total assets of $68,039 and shareholders' equity of −$14.7m.

U.S.Stem Cell, Inc. is a biotechnology company, which focuses on the discovery, development, and subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. The company is headquartered in Sunrise, Florida. The company went IPO on 2008-02-19. Stem Cell, Inc., formerly Bioheart, Inc., is a biotechnology company. The firm is focused on the discovery, development and, subject to regulatory approval, commercialization of autologous cell therapies for the treatment of chronic and acute heart damage. Its MyoCell is a clinical therapy designed to populate regions of scar tissue within a patient's heart with autologous muscle cells, or cells from a patient's body, for the purpose of improving cardiac function in chronic heart failure patients. Its AdipoCell is a cell therapy with multiple possible treatment applications using autologous adipose cells. Its business includes the development of cell therapy products, as well as physician and patient-based regenerative medicine/cell therapy training services, and the sale of cell collection and treatment kits for humans and animals, and the operation of a cell therapy clinic. The company operates through divisions, including US Stem Cell Training, Vetbiologics and US Stem Cell Clinic.

Figures and description from our data supplier, not checked against the company's own report.

More about US Stem Cell →

Latest on US Stem Cell

Our reporting

We have not reported on US Stem Cell yet.

Other Health Care listings

Scenario calculator

Try your own numbers. This is arithmetic, not a forecast.

Interactive

Gain or loss

—

Return

—

Leaves out fees, taxes and financing.

Frequently asked questions

What is US Stem Cell's ticker?

US Stem Cell trades as USRM on its US listing, under ISIN US90350U1007.

What was US Stem Cell's last closing price?

0.00 on 9 Nov 2026. The figure is in USD and is never converted.

Sources and methodology

Chart
TradingView
Close and company data
Our data supplier
News
Our reporting

Nothing here is investment advice. Prices can be delayed or wrong, so check with the exchange before relying on them. Data for this page. How we cover markets.